XFBLD-Platform: a crystallographic fragment-screening platform at Shanghai Synchrotron Radiation Facility
Acta Crystallographica Section D Structural Biology · 01.09.2025 · 81 (9) · 482-491
DOI: 10.1107/s2059798325006801 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Crystallographica Section D Structural Biology, online erschienen am 11.08.2025. Verfasst von Liqing Huang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, People's Republic of China. Hauptthemen laut MEDLINE: Synchrotrons, Drug Discovery. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Fragment-based lead discovery (FBLD) is an efficient and effective method for identifying novel chemical scaffolds that have advantages in drug development. X-ray crystallography has an inherent advantage in recognizing low-affinity fragments and integrates fragment identification with complex structure determination, making it an increasingly important tool for screening fragment compounds. Here, we introduce a crystallographic fragment-screening platform developed by the biological macromolecular crystallography group at Shanghai Synchrotron Radiation Facility, named the XFBLD-Platform. This platform promotes fragment-based lead discovery through a comprehensive workflow that includes high-throughput complex crystal preparation, crystal harvesting, diffraction data collection and analysis, and fragment-affinity estimation. It integrates advanced hardware, high-performance beamline facilities and specialized experimental design and data-management software. The platform provides a rapid and practical approach for structure-based drug development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, People's Republic of China.
- Shanghai Synchrotron Radiation Facility, Shanghai Advanced Research Institute, Chinese Academy of Sciences, Shanghai 201204, People's Republic of China.
ORCID-Profile: Liqing Huang, Zhimin Zhu, Qin Xu, Feng Yu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Huang, L., Wang, W., Zhu, Z., Li, Q., Li, M., Zhou, H., Xu, Q., Wang, Q., & Yu, F. (2025). XFBLD-Platform: a crystallographic fragment-screening platform at Shanghai Synchrotron Radiation Facility. Acta Crystallographica Section D Structural Biology, 81(9), 482-491. https://doi.org/10.1107/s2059798325006801
Vancouver
Huang L, Wang W, Zhu Z, Li Q, Li M, Zhou H, et al. XFBLD-Platform: a crystallographic fragment-screening platform at Shanghai Synchrotron Radiation Facility. Acta Crystallographica Section D Structural Biology. 2025;81(9):482-491. doi:10.1107/s2059798325006801
BibTeX
@article{Huang2025,
author = {Huang, Liqing and Wang, Weiwei and Zhu, Zhimin and Li, Qianhui and Li, Minjun and Zhou, Huan and Xu, Qin and Wang, Qisheng and Yu, Feng},
title = {XFBLD-Platform: a crystallographic fragment-screening platform at Shanghai Synchrotron Radiation Facility},
journal = {Acta Crystallographica Section D Structural Biology},
year = {2025},
volume = {81},
number = {9},
pages = {482--491},
doi = {10.1107/s2059798325006801}
}
EUVIMED